🔖
Cite This Article
SOOKAROMDEE, P., WIWANITKIT, V. (2019). Wilms Tumor-1 (WT1) rs16754 Polymorphism. Turkish Journal of Hematology, Cilt: 36 - Sayı: 1, 69–69. https://ajindex.com/articles/412383
Journals / Turkish Journal of Hematology / 2019 / Cilt: 36 - Sayı: 1
Wilms Tumor-1 (WT1) rs16754 Polymorphism
- Pages
- 69–69
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (4)
- Ramzi M, Moghadam M, Cohan N. Wilm’s tumor-1 (WT1) rs16754 polymorphism and clinical outcome in acute myeloid leukemia. Turk J Hematol 2019;36:67-68
- Petiti J, Rosso V, Lo Iacono M, Calabrese C, Signorino E, Gaidano V, Berger M, Saglio G, Cilloni D. Prognostic significance of the Wilms’ tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia. Leuk Res 2018;67:6-11
- He X, Chen P, Yang K, Liu B, Zhang Y, Wang F, Guo Z, Liu X, Lou J, Chen H. Association of MDM2 polymorphism with risk and prognosis of leukemia: a meta-analysis. Acta Haematol 2015;133:365-371
- Yan H, Zhang DY, Li X, Yuan XQ, Yang YL, Zhu KW, Zeng H, Li XL, Cao S, Zhou HH, Zhang W, Chen XP. Long non-coding RNA GAS5 polymorphism predicts a poor prognosis of acute myeloid leukemia in Chinese patients via affecting hematopoietic reconstitution. Leuk Lymphoma 2017;58:1948- 1957.